Public Employees Retirement System of Ohio bought a new position in Humana Inc. (NYSE:HUM – Free Report) during the second quarter, Holdings Channel reports. The firm bought 62,394 shares of the insurance provider’s stock, valued at approximately $24,784,000.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in Humana in the 2nd quarter worth approximately $4,138,160,000. Pzena Investment Management LLC purchased a new stake in shares of Humana during the 2nd quarter worth approximately $1,749,014,000. Capital International Investors boosted its position in shares of Humana by 113.9% during the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after acquiring an additional 3,097,571 shares during the last quarter. Norges Bank bought a new position in shares of Humana during the 4th quarter valued at approximately $456,632,000. Finally, Wellington Management Group LLP grew its holdings in shares of Humana by 4,481.7% in the fourth quarter. Wellington Management Group LLP now owns 1,196,502 shares of the insurance provider’s stock valued at $306,460,000 after purchasing an additional 1,170,387 shares in the last quarter. 92.38% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Several equities research analysts recently weighed in on the stock. Sanford C. Bernstein restated an “outperform” rating and issued a $425.00 price target on shares of Humana in a research report on Wednesday, June 3rd. Bank of America raised shares of Humana from a “neutral” rating to a “buy” rating and set a $500.00 price objective for the company in a research note on Wednesday, July 29th. Needham & Company LLC started coverage on shares of Humana in a report on Wednesday, May 20th. They issued a “buy” rating on the stock. Wells Fargo & Company upgraded shares of Humana from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $227.00 to $502.00 in a research report on Monday, July 13th. Finally, Evercore raised shares of Humana from an “in-line” rating to an “outperform” rating and set a $480.00 price target for the company in a report on Wednesday, July 29th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $403.91.
Humana Stock Down 1.5%
Shares of HUM opened at $386.92 on Friday. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The business has a fifty day moving average of $385.60 and a 200 day moving average of $288.47. The company has a market cap of $46.46 billion, a PE ratio of 36.61, a P/E/G ratio of 2.20 and a beta of 0.72. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88.
Humana (NYSE:HUM – Get Free Report) last announced its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, beating the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. During the same quarter in the prior year, the firm posted $6.27 earnings per share. The business’s revenue for the quarter was up 26.2% on a year-over-year basis. On average, sell-side analysts expect that Humana Inc. will post 9.12 EPS for the current year.
Humana Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Articles
- Five stocks we like better than Humana
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
